Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Glaucoma > Visit-handling methods significantly affect reported glaucoma surgery success rates
  • Glaucoma

Visit-handling methods significantly affect reported glaucoma surgery success rates

Ophthalmology 360

Key Takeaways

  1. Visit-handling methods significantly affect reported glaucoma surgery success rates, with the highest rates seen when the lowest IOP is used and the lowest rates when peak or all IOP values are considered.
  2. Intermediate success rates are observed when using mean, median, or closest IOP values, highlighting variability based on analytic approach.
  3. IOP-based success definitions show limited correlation with visual field outcomes, as substantial overlap in progression rates persists across all methods.

Different strategies for handling multiple intraocular pressure (IOP) measurements within follow-up time windows can substantially alter reported success rates after glaucoma surgery, according to a study.

Researchers applied standard high-IOP failure criteria to 934 trabeculectomy-treated eyes and 1760 deep sclerectomy-treated eyes, with approximately 41–45 months of follow-up. Multiple visit-handling strategies (mean, median, highest, lowest, closest, or all IOP values) were compared using Kaplan-Meier success estimates.

At a 21 mm Hg threshold, the highest 5-year success rates were observed when the lowest recorded IOP was used (54.8% for trabeculectomy and 74.5% for deep sclerectomy). Lower success rates were seen with approaches using peak IOP (39.3% and 60.4%, respectively) or incorporating all visits (38.8% and 61.0%). Intermediate results were reported when using mean, median, or the closest IOP values.

In a subset of patients undergoing trabeculectomy with sufficient visual field data, eyes classified as failures showed faster progression of mean deviation compared with those labeled as successes. However, there was considerable overlap in progression rates between groups regardless of the visit-handling method used.

Reference

Rabiolo A, Khaliliyeh D, Jin SW, et al. Impact of visit schedule on estimated success rates in glaucoma surgical studies. Br J Ophthalmol. 2026;bjo-2025-329283. doi: 10.1136/bjo-2025-329283. Epub ahead of print. PMID: 42055787.

Share

Related Content

  • Glaucoma

Expanding the glaucoma treatment landscape with FLIGHT technology

  • Glaucoma

Geographic differences in glaucoma care raise concerns about equitable access

  • Glaucoma

Study finds significant IOP reductions with iDose TR and MIGS procedures

  • Glaucoma

EyeValve device lowers IOP and maintains control for 9 months in first-in-human study

  • Glaucoma

GLP-1 therapies may offer potential benefits in glaucoma

  • Glaucoma

PreserFlo MicroShunt shows short-term benefit in refractory childhood glaucoma

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon